NEI
ABMD

Northwest & Ethical Investments’s Abiomed Inc ABMD Stock Holding History

Northwest & Ethical Investments’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12,396
Closed -$3.05M – 433
2022
Q3 		$3.05M Hold
12,396
– – 0.12% 195
2022
Q2 		$3.07M Buy
12,396
+518
+4% +$140K 0.12% 198
2022
Q1 		$3.93M Buy
11,878
+7,278
+158% +$2.24M 0.13% 194
2021
Q4 		$1.65M Buy
+4,600
New +$1.55M 0.05% 255
2018
Q4 		– Sell
-100
Closed -$45K – 410
2018
Q3 		$45K Sell
100
-200
-67% -$78.8K ﹤0.01% 354
2018
Q2 		$123K Sell
300
-100
-25% -$36.2K 0.01% 345
2018
Q1 		$116K Sell
400
-300
-43% -$76K 0.01% 339
2017
Q4 		$131K Buy
+700
New +$131K 0.01% 331

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Northwest & Ethical Investments's ABMD Position: Q4 2022 in Review

Northwest & Ethical Investments sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 12,396 shares — an estimated $3.05M sold.

Northwest & Ethical Investments first reported a position in ABMD in Q4 2017 and held it in 8 quarters. The position peaked at $3.93M in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Northwest & Ethical Investments reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Northwest & Ethical Investments sold 12,396 Abiomed Inc shares in Q4 2022, an estimated $3.05M.
  • Northwest & Ethical Investments first reported a position in Abiomed Inc in Q4 2017 and held it in 8 quarters.
  • Northwest & Ethical Investments's Abiomed Inc position peaked at $3.93M in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Northwest & Ethical Investments's 13F filing for Q4 2022, filed 9 Jul 2025.